Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Apr 28, 2025; 31(16): 104758
Published online Apr 28, 2025. doi: 10.3748/wjg.v31.i16.104758
Table 3 Stratified analysis

Conditional independence tests (χ2, P value)
OR parity test (P value)
Estimated combined OR (95%CI)
Age (≤ 51, > 51), year26.588, P = 0.0000.20810.850 (3.726-31.594)
Fever19.673, P = 0.0000.6359.254 (2.998-28.569)
CMV positivity21.170, P = 0.0000.71210.669 (3.361-33.867)
Fungal infection30.291, P = 0.0000.43714.969 (4.875-45.962)
Hemoglobin (≤ 113, >113) g/L22.047, P = 0.0000.70812.459 (3.726-41.661)
CRP (≤ 11.74, > 11.74) mg/L16.495, P = 0.0000.33910.979 (3.071-39.245)
ESR (≤ 27, > 27) mm/hour28.514, P = 0.0000.36912.056 (4.070-35.715)
Albumin (≤ 35.2, > 35.2) g/L20.065, P = 0.0000.5989.897 (3.119-31.409)
Prealbumin (≤ 163, >163) g/L28.164, P = 0.0000.12710.992 (3.822-31.612)
Treatment with ≥ 3 types of immunosuppressive drugs before admission42.469, P = 0.0000.82525.583 (7.836-83.531)
Antibiotic therapy with third-generation cephalosporins or more advanced antibiotics during admission23.298, P = 0.0000.08712.659 (4.035-39.719)